Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse CALCB ELISA Kit (AC3782)
Cat.#: ASET-2371
Specifications
Description Mouse CALCB ELISA Kit allows for the in vitro quantitative determination of mouse CALCB concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2389 Human Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3800) Quantitative inquiry ASET-2506 Bovine Antidiuretic Hormone ELISA Kit (AC3917) Quantitative inquiry ASET-2111 Rat FADS2 ELISA Kit (AC3522) Quantitative inquiry ASET-1542 Human SLUG ELISA Kit (AC2953) Quantitative inquiry ASET-2462 Human Zyxin ELISA Kit (AC3873) Quantitative inquiry ASET-2397 Human Gigaxonin ELISA Kit (AC3808) Quantitative inquiry ASET-1288 Human Somatostatin Receptor 2 ELISA Kit (AC2699) Quantitative inquiry ASET-1831 Human SFRP1 ELISA Kit (AC3242) Quantitative inquiry ASET-1251 Human PICALM ELISA Kit (AC2662) Quantitative inquiry ASET-1422 Mouse Ataxin 1 ELISA Kit (AC2833) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket